Tolerability and efficacy of erythropoietin (EPO) treatment in traumatic spinal cord injury: a preliminary randomized comparative trial vs. methylprednisolone (MP).
about
Drug delivery, cell-based therapies, and tissue engineering approaches for spinal cord injuryBiomaterials for Local, Controlled Drug Delivery to the Injured Spinal Cord.Harms of off-label erythropoiesis-stimulating agents for critically ill people.Investigation of efficacy of treatment in spinal cord injury: Erythropoietin versus methylprednisolone.Erythropoietin signaling increases neurogenesis and oligodendrogenesis of endogenous neural stem cells following spinal cord injury both in vivo and in vitro.
P2860
Tolerability and efficacy of erythropoietin (EPO) treatment in traumatic spinal cord injury: a preliminary randomized comparative trial vs. methylprednisolone (MP).
description
2015 nî lūn-bûn
@nan
2015年の論文
@ja
2015年学术文章
@wuu
2015年学术文章
@zh
2015年学术文章
@zh-cn
2015年学术文章
@zh-hans
2015年学术文章
@zh-my
2015年学术文章
@zh-sg
2015年學術文章
@yue
2015年學術文章
@zh-hant
name
Tolerability and efficacy of e ...... l vs. methylprednisolone (MP).
@en
Tolerability and efficacy of erythropoietin
@nl
type
label
Tolerability and efficacy of e ...... l vs. methylprednisolone (MP).
@en
Tolerability and efficacy of erythropoietin
@nl
prefLabel
Tolerability and efficacy of e ...... l vs. methylprednisolone (MP).
@en
Tolerability and efficacy of erythropoietin
@nl
P2093
P2860
P1476
Tolerability and efficacy of e ...... l vs. methylprednisolone (MP).
@en
P2093
Alfredo Gorio
Cristina Pagliacci
Davide Dalla Costa
Elisabetta Pupillo
Franco Faccioli
Paola Carignano
Paolo Messina
Tiziana Redaelli
P2860
P2888
P304
P356
10.1007/S10072-015-2182-5
P50
P577
2015-03-28T00:00:00Z